Construction and identification of a human liver specific microRNA eukaryotic expression vector

MiR-122 is one of the non-coding RNAs which showed its effects on the lipo-metablism, virus infection and HCC forming through regulation of liver gene expression. Its eukaryotic expression vector was constructed by using pSuper which was widely applied in the siRNA expression. The precursor of human miR-122 gene was amplified by polymerase chain reaction （PCR） from the human genomic DNA. The positive clones were screened by PCR and restriction enzyme digestion. The new expression vector of miR-122 was named pHsa-m122. PHsa-m122 and its controls were transfected to HepG2 cells. The miR-122 expression activity was evaluated by GFP122i sensor reporter plasmid through fluorescence detection and Western blot. It was shown that the fluorescence intensity of GFP122si and pHsa-m122 co-transfection group was weaker than that of the controls, so the functional activity of expressed miR-122 was detected. When HepG2 cells were co-transfected with HBV1.3 and pHsa-m122 plasmids, the results showed miR-122 may down-regulate the gene expression of HBV. The human liver specific microRNA eukaryotic expression vector of miR-122 was constructed successfully, which may facilitate further study of its function in the development of liver virus infection diseases and HCC. Cellular ＆ Molecular Immunology.     

Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions.

Because collagen is a major component of the human atherosclerotic plaque, factors controlling collagen synthesis may have a profound influence on the volume growth of these intimal lesions. In human arteries, we compared normal vs atherosclerotic media vs intimas for type I collagen gene expression using immunocytochemistry and in situ messenger RNA hybridization with subsequent correlations with plaque topographical features. We also determined the associations of such collagen gene expression with proximity to monocyte/macrophages and T lymphocytes. Type I collagen synthesis appears to be upregulated in atherosclerotic plaques compared with their underlying medias and normal internal mammary arteries and coronary diffuse intimal thickenings. At least in established and advanced coronary and carotid plaques, type I collagen gene expression is focal and especially prevalent in fibrous cap and vascularized regions. Although macrophages and type I procollagen messenger RNA and protein are both found in atherosclerotic plaques, no apparent spatial correlation between macrophage presence and type I procollagen presence was found within these atherosclerotic intimas. Type I procollagen presence appears to be negatively associated with the spatial presence of T cells. Thus, human atherosclerotic plaques exhibit nonuniform patterns of type I collagen gene expression. Although the biochemical determinants of this focal gene expression have yet to be determined, it is conceivable that stimulatory/inhibitory cytokines and other factors (eg hemodynamics) play important roles in determining the focal nature of collagen synthesis in atherosclerosis.     

Alterations of endothelin-converting enzyme expression in early and advanced stages of human coronary atherosclerosis

Endothelin-1 is a potent vasoconstrictor and exhibits a mitogenic activity on vascular smooth muscle cells (SMCs). Endothelin-converting enzyme (ECE) is the final key enzyme of endothelin-1 processing. We studied the immunolocalization of ECE in human coronary atherosclerotic lesions with different disease stages. Frozen sections of normal coronary arteries with diffuse intimal thickening (n=13) and those of coronary arteries with early (n=10) or advanced atherosclerotic plaques (n=13) were studied. Monoclonal antibodies used were directed against SMCs, macrophages, endothelial cells, and ECE. For the identification of cell types that express ECE, double immunostaining analysis was also used. In normal coronary arteries, ECE immunoreactivity was observed in luminal endothelial cells and medial SMCs. Early atherosclerotic plaques, which consisted predominantly of SMCs, showed enhanced ECE expression in luminal endothelial cells and intimal SMCs. In advanced atherosclerotic plaques, distinct ECE expression was found in accumulated macrophages and in endothelial cells of intraplaque microvessels, while luminal endothelial cells showed relatively weak immunoreactivity for ECE. In conclusion, the present study demonstrates that the major cell types expressing ECE within the plaques are different between early and advanced stages of human coronary atherosclerosis. Enhanced ECE expression and possible endothelin-1 generation may contribute to SMC proliferation and vasoconstriction in early atherosclerotic stages, and may promote plaque destabilization in advanced atherosclerotic stages.     

人髂动脉粥样硬化斑端粒酶活性检测

目的:探讨动脉粥样硬化形成与血管平滑肌细胞端粒酶活性表达的相关性。方法:取20例肾功能衰竭患者髂动脉粥样硬化斑及5例脑死亡病人正常髂动脉组织, 刮去腔面内膜层及外膜结缔组织后, 用端粒重复序列扩增法(Telomericrepeatsequenceamplificationprotocol, TRAP)检测剩余组织端粒酶活性。结果:5例正常髂动脉组织均为端粒酶阴性, 20例动脉粥样硬化组织中, 有8例为阳性, 12例呈阴性。结论:端粒酶与血管平滑肌细胞增生及动脉粥样硬化形成可能存在一定相关性, 其作用待进一步研究。     

microRNA的组织特异性表达及其检测方法

microRNA（miRNA）是一类调节基因表达的非编码的小RNA。miRNA参与细胞的分化、增殖及凋亡等多种生命活动,并与多种疾病的发生和发展密切相关。miRNA表达存在组织特异性,而疾病（包括肿瘤）的发生和发展也表现为某些miRNA的表达失调。miRNA相关研究均需检测细胞的miRNA表达水平,常用杂交和RT—PCR等方法检测。     

靶向调控c-SKI的microRNA的筛选及验证

目的筛选和验证靶向调控c-SKI并与纤维化相关的microRNA(miRNA)。方法生物信息学方法预测并结合文献报道,筛选出靶向c-SKI的候选miRNAs,RT-qPCR检测人心肌成纤维细胞(HCFBs)中候选miRNAs和c-SKI的表达,筛选出抑制作用最显著的miRNA;构建c-SKI-3′-UTR野生型(c-SKI-wt)和突变型(c-SKI-mut)载体,分别与miR-155a-5p/miR-17a-5p的模拟物、抑制剂及对照在人胚肾上皮细胞(HEK293T)中共转染,双萤光素酶报告系统检测各组荧光素酶活性;接着,分别将miR-155a/miR-17a-5p mimics和inhibitor转染至人心肌成纤维细胞(HCFBs),Western blot检测各组细胞c-SKI的表达。结果 1)经筛选miR-155a-5p和miR-17a-5p对c-SKI的抑制作用最明显(P<0.01);2)与NC组相比,miR-155a-5p/miR-17a-5p mimics组萤光素酶活性均显著下降(P<0.05),miR-155a-5p/miR-17a-5p inhibitor组萤光素酶活性均明显增强(P<0.05);3)与NC组相比,miR-155a-5p/miR-17a-5p mimics组中c-SKI蛋白表达显著下调,miR-155a-5p/miR-17a-5p inhibitor组中c-SKI的表达显著上调(P<0.01)。结论 miR-155a-5p和miR-17a-5p可分别靶向结合c-SKI的3′-UTR,在HCFBs中负性调控c-SKI的表达。     

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

BACKGROUND. Atherosclerosis is characterized by endothelial injury and the proliferation of arterial smooth-muscle cells. The latter may be a result of the release of growth factors from the vessel wall; such growth factors may include an endothelium-derived vasoconstrictor for peptide with mitogenic properties. We tested the hypothesis that plasma endothelin concentrations are elevated in persons with symptomatic atherosclerosis, independently of age. METHODS. We measured plasma endothelin levels in 100 normal subjects and in 40 patients with atherosclerosis predominantly of the following types: aortic and peripheral vascular disease (14 patients), renovascular disease (9 patients) coronary artery disease (9 patients), and carotid disease (8 patients). We also performed immunohistochemical staining for endothelin in the walls of atherosclerotic vessels. RESULTS. In the normal subjects, the mean (+/- SD) plasma endothelin concentration was 1.4 +/- 0.2 pmol per liter, with no correlation between age and plasma endothelin concentration (r = 0.13, P = 0.2). In the patients with symptomatic atherosclerosis, the mean plasma endothelin concentration was 3.2 +/- 1.2 pmol per liter (P less than 0.001), and there was a significant correlation between plasma endothelin and the number of sites of disease involvement (r = 0.89, P less than 0.001). In the immunohistochemical studies, endothelin-1-like immunoreactivity was observed in vascular smooth muscle as well as in endothelial cells. CONCLUSIONS. Endothelin may be a marker for arterial vascular disease. Whether it participates in the atherogenic process or is merely released from damaged endothelial cells is unclear.     

Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis

MicroRNAs (miRNAs) are studied as key regulators of gene expression involved in different diseases. Several single nucleotide polymorphisms (SNPs) in miRNA genes or target sites (miRNA-related SNPs) have been proved to be associated with human diseases by affecting the miRNA-mediated regulatory function. To systematically analyze miRNA-related SNPs and their effects, we performed a genome-wide scan for SNPs in human pre-miRNAs, miRNA flanking regions, target sites, and designed a pipeline to predict the effects of them on miRNA-target interaction. As a result, we identified 48 SNPs in human miRNA seed regions and thousands of SNPs in 3' untranslated regions with the potential to either disturb or create miRNA-target interactions. Furthermore, we experimentally confirmed seven loss-of-function SNPs and one gain-of-function SNP by luciferase assay. This is the first case of experimental validation of an SNP in an miRNA creating a novel miRNA target binding. All useful data were complied into miRNASNP, a user-friendly free online database (http://www.bioguo.org/miRNASNP/). These data will be a useful resource for studying miRNA function, identifying disease-associated miRNAs, and further personalized medicine.     

Preliminary and early stages of atherosclerosis in childhood

According to the unified theory of atherosclerosis, endothelial cell injury and lipid infiltration play an important role in atherogenesis. Newborn babies may suffer endothelial cell damage, as may be detected by electron microscopy. Connective tissue elements are occasionally abundant already in newborns. Chondroitin sulfate A and C increase with age. The children may exhibit continuous accumulation of cholesterol esters in the intima of coronary arteries. Cholesteryl ester fatty acid composition, along with age, tends to approach that of serum low-density lipoproteins. Fatty streaks appear in coronary arteries in puberty, and fibrous plaques are recordable beyond the age of 20 years. The topography of myo-intimal thickenings, fatty streaks, and fibrous plaques is similar to complicated atherosclerotic lesions. Even newborn babies have obstructive myo-intimal thickenings in their coronary arteries. One fifth of all infants under one week of age suffer 20% stenosis, with percentile manifestation of stenosis in the arterial cross-section being established as ratio of intimal area to luminal area of a dilated coronary artery multiplied by 100. Occasionally, the intima is very thick, in our series initiating up to 57% of all narrowing. There are probably noxious factors which temporarily damage the endothelial cells and initiate a rapid, partially reversible thickening reaction. Some of this response of the intima to exogenous stimuli might be genetically determined. A thickened intima is susceptible to lipid deposition and atherosclerosis.     

Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis

The growth arrest-specific gene 6 (Gas6) plays a role in pro-atherogenic processes such as endothelial and leukocyte activation, smooth muscle cell migration and thrombosis, but its role in atherosclerosis remains uninvestigated. Here, we report that Gas6 is expressed in all stages of human and mouse atherosclerosis, in plaque endothelial cells, smooth muscle cells and macrophages. Gas6 expression is most abundant in lesions containing high amounts of macrophages, ie thin fibrous cap atheroma and ruptured plaque. Genetic loss of Gas6 does not affect the number and size of initial and advanced plaques in ApoE(-/-) mice, but alters its plaque composition. Compared to Gas6(+/+): ApoE(-/-) mice, initial and advanced plaques of Gas6(-/-): ApoE(-/-) mice contained more smooth muscle cells and more collagen and developed smaller lipid cores, while the expression of TGFbeta was increased. In addition, fewer macrophages were found in advanced plaques of Gas6(-/-): ApoE(-/-) mice. Hence, loss of Gas6 promotes the formation of more stable atherosclerotic lesions by increasing plaque fibrosis and by attenuating plaque inflammation. These findings identify a role for Gas6 in plaque composition and stability.     

In vivo Raman spectral pathology of human atherosclerosis and vulnerable plaque

The rupture of vulnerable atherosclerotic plaque accounts for the majority of clinically significant acute cardiovascular events. Because stability of these culprit lesions is directly related to chemical and morphological composition, Raman spectroscopy may be a useful technique for their study. Recent developments in optical fiber probe technology have allowed for the real-time in vivo Raman spectroscopic characterization of human atherosclerotic plaque demonstrated in this work. We spectroscopically examine 74 sites during carotid endarterectomy and femoral artery bypass surgeries. Of these, 34 are surgically biopsied and examined histologically. Excellent signal-to-noise ratio spectra are obtained in only 1 s and fit with an established model, demonstrating accurate tissue characterization. We also report the first evidence that Raman spectroscopy has the potential to identify vulnerable plaque, achieving a sensitivity and specificity of 79 and 85%, respectively. These initial findings indicate that Raman spectroscopy has the potential to be a clinically relevant diagnostic tool for studying cardiovascular disease.     

Fractalkine及其受体CX3CR1蛋白在兔动脉粥样硬化斑块中表达增加

动脉粥样硬化(athemsclemsis,AS)是危害人类健康的主要疾病.炎性反应贯穿了AS发生、发展的整个过程.趋化因子可能通过驱动、调节黏附分子的表达或直接趋化、吸引炎性细胞,导致炎性反应.     

Intimal plaque development and oxidative stress in cholesterol-induced atherosclerosis in New Zealand rabbits

Although oxidative stress is well known in atherogenesis, the origin, nature and kinetics of free radicals involved have not been well described till now. Here, we correlated parameters of oxidative stress with cellular components during induction and stabilization of aortic intimal lesions which were induced in rabbits by feeding a cholesterol-enriched diet for 6 weeks and a normal diet for further 68 weeks. Plasma lipids, aortic plaque size and composition (macrophages, smooth muscle cells, oxidized LDL by morphometry), as well as aortic radical production (by luminol-enhanced chemiluminescence and TEMPO-9AC fluorescence) were measured after various time points. The parameters of oxidative stress were correlated with the different cellular components of the aortic plaques. The plaques increased until week 21, no significant regression was found until week 74, plasma cholesterol was maximal at week 6. Macrophages, oxidized LDL and generation of different species of free radicals were increased during plaque development, yet with different time kinetics. Whereas chemiluminescence correlated only weakly with the amount of intimal macrophages, strong correlations were found between TEMPO fluorescence and smooth muscle cells (r = 0.4778, P < 0.001) and between macrophages and oxidized LDL (r = 0.5896, P < 0.0001). Different indicators of oxidative stress were increased during plaque progression and stabilization. However, the various correlations show, that distinct types of reactive species secreted probably from macrophages and smooth muscle cells contribute to oxidative stress in the different phases of plaque development.     

The microglial phagocytic role with specific plaque types in the Alzheimer disease brain

Alzheimer disease (AD) involves glial inflammation associated with amyloid plaques. The role of the microglial cells in the AD brain is controversial, as it remains unclear if the microglia form the amyloid fibrils of plaques or react to them in a macrophage-phagocytic role. Also, it is not known why microglia are preferentially associated with some amyloid plaque types. This review will provide substantial evidence to support the phagocytic role of microglia in the brain as well as explain why microglia are generally associated with specific plaque types that may be explained through their unique mechanisms of formation. In summary, the data presented suggests that plaque associated microglial activation is typically subsequent to specific amyloid plaque formations in the AD brain.     

The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis

Accumulating evidence supports the notion that defective phagocytic clearance of dying cells, or defective "efferocytosis," is causally linked to the progression of advanced atherosclerosis. In advanced atherosclerotic lesions, defective efferocytosis leads to post-apoptotic necrosis, expansion of plaque necrotic cores, and susceptibility to atherothrombosis. Both macrophages and DC-like efferocytes are juxtaposed near expanding necrotic cores, where they engage apoptotic cells. In this Viewpoint, we discuss how reduced efferocytosis by macrophages and CD11c(HI) DC-like cells may combine to reduce overall plaque stability and therefore promote susceptibility to acute atherothrombosis.     

Isolating early cortical generators of visual-evoked activity: a systems identification approach

The VESPA (visual-evoked spread spectrum analysis) method estimates the impulse response of the visual system using a continuously varying stimulus. It has been used recently to address both basic cognitive and neurophysiologic questions as well as those surrounding clinical populations. Although the components of the average VESPA response are highly reminiscent of the early components of the visual-evoked potential (VEP) when measured over midline occipital locations, the two responses are acquired in different ways and, thus, they cannot be regarded as being equivalent. To further characterize the relationship between the VESPA and the VEP and the generative mechanisms underlying them, we recorded EEG from 31 subjects in response to checkerboard-based VEP and VESPA stimuli. We found that, across subjects, the amplitudes of the VEP C1 component and the VESPA C1 component were highly correlated, whereas the VEP P1 and the VESPA P1 bore no statistical relationship. Furthermore, we found that C1 and P1 amplitudes were significantly correlated in the VESPA but not in the VEP. We believe these findings point to the presence of common generators underlying the VESPA C1 and the VEP C1. We argue further that the VESPA P1, in light of its strong relationship to the VESPA C1, likely reflects further activation of the same cortical generators. Given the lack of correlation between the VEP P1 and each of these three other components, it is likely that the underlying generators of this particular component are more varied and widespread, as suggested previously. We discuss the implications of these relationships for basic and clinical research using the VESPA and for the assessment of additive-evoked versus phase-reset contributions to the VEP.     

The morphology of the early stages of experimental myocardial infarct in atherosclerosis

Summary The following operations were performed in rabbits with and without atherosclerosis. At one operation, the left vagus was ligatured and the left anterior descending coronary artery divided. The first sign of a disturbance of the coronary circulation was that glycogen disappeared diffusely from the myocardium of rabbits of the atherosclerotic group, while from those which were free from atherosclerosis it disappeared from certain foci. Vascular disturbances and myocardial dystrophy appeared early in the atherosclerotic rabbits, and were more pronounced than in the operated controls. Protein dystrophy of cardiac muscle is revealed by the distinctive reaction to staining by Selye's method. Disappearance of glycogen from the ischemic zone, and fuchsinophilia of the muscle fibers in this zone constitute a morphological test for the early stages of myocardial infarction.Presented by Active Member AMN SSSR V. V. Parin Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 53, No. 1, pp. 117–121, January, 1962